Biocardia Said Co, Cantor Fitzgerald Agreed To Indefinitely Suspend Sales Under Co's Controlled Equity Offering Sales Agreement, Dated April 12
Portfolio Pulse from Charles Gross
Biocardia and Cantor Fitzgerald have agreed to indefinitely suspend sales under the company's Controlled Equity Offering Sales Agreement, dated April 12.
June 20, 2023 | 9:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biocardia's sales under the Controlled Equity Offering Sales Agreement with Cantor Fitzgerald have been suspended indefinitely.
The indefinite suspension of sales under the Controlled Equity Offering Sales Agreement may negatively impact Biocardia's stock price in the short term, as it could signal potential issues with the agreement or the company's financial position.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100